These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 24106037)

  • 1. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
    Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
    Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of malignant neoplasms after liver transplantation: a population-based study.
    Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
    Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.
    Baccarani U; Piselli P; Serraino D; Adani GL; Lorenzin D; Gambato M; Buda A; Zanus G; Vitale A; De Paoli A; Cimaglia C; Bresadola V; Toniutto P; Risaliti A; Cillo U; Bresadola F; Burra P
    Dig Liver Dis; 2010 Jan; 42(1):55-60. PubMed ID: 19497797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014.
    Taborelli M; Piselli P; Ettorre GM; Lauro A; Galatioto L; Baccarani U; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Sforza D; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Burra P; Rossi M; Tisone G; Zamboni F; Serraino D;
    Int J Cancer; 2018 Oct; 143(7):1588-1594. PubMed ID: 29693248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo malignancies after liver transplantation: a major cause of late death.
    Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008.
    Ettorre GM; Piselli P; Galatioto L; Rendina M; Nudo F; Sforza D; Miglioresi L; Fantola G; Cimaglia C; Vennarecci G; Vizzini GB; Di Leo A; Rossi M; Tisone G; Zamboni F; Santoro R; Agresta A; Puro V; Serraino D
    Transplant Proc; 2013 Sep; 45(7):2729-32. PubMed ID: 24034034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
    Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study.
    Jiang Y; Villeneuve PJ; Fenton SS; Schaubel DE; Lilly L; Mao Y
    Liver Transpl; 2008 Nov; 14(11):1588-97. PubMed ID: 18975293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.
    Kellerman L; Neugut A; Burke B; Mancini D
    Am J Cardiol; 2009 Feb; 103(4):562-6. PubMed ID: 19195521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of de novo malignancy in the liver transplant recipient.
    Chandok N; Watt KD
    Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo tumors are a major cause of late mortality after orthotopic liver transplantation.
    Baccarani U; Adani GL; Serraino D; Lorenzin D; Gambato M; Buda A; Zanus G; Vitale A; Piselli P; De Paoli A; Bresadola V; Risaliti A; Toniutto P; Cillo U; Bresadola F; Burra P
    Transplant Proc; 2009 May; 41(4):1303-5. PubMed ID: 19460546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
    Sérée O; Altieri M; Guillaume E; De Mil R; Lobbedez T; Robinson P; Segol P; Salamé E; Abergel A; Boillot O; Conti F; Chazouillères O; Debette-Gratien M; Debray D; Hery G; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Jacquemin E; Kamar N; Latournerie M; Lebray P; Leroy V; Mazzola A; Neau-Cransac M; Pageaux GP; Radenne S; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Launoy G; Dumortier J
    Liver Transpl; 2018 Oct; 24(10):1425-1436. PubMed ID: 30021061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
    Dreyer L; Faurschou M; Mogensen M; Jacobsen S
    Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant malignancies in liver transplant recipients.
    Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo malignancies following liver transplantation: impact and recommendations.
    Herrero JI
    Liver Transpl; 2009 Nov; 15 Suppl 2():S90-4. PubMed ID: 19877025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
    Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
    J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.